CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating Activities:
Net (loss) income	$ (118,384)	$ (148,149)
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation	73,358	77,876
Amortization of intangibles	4,894	5,141
Loss on sale of businesses, net	0	334
Impairment charges	0	654
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement	44,571	0
Share-based compensation expense	7,057	4,071
Equity in (earnings) losses of affiliates, net of dividends related to earnings	(1,199)	1,159
Loss on refinancing and extinguishment of debt	0	81,885
Paid-in-Kind Interest	12,367	44,019
Deferred income taxes	1,889	(586)
Other	4,036	3,606
Changes in operating assets and liabilities	(26,942)	(32,394)
Net cash provided by operating activities	1,647	37,616
Investing activities:
Capital expenditures	(39,014)	(63,184)
Proceeds from Divestiture of Businesses, Net of Cash Divested	0	15,351
Other	287	358
Net cash used in investing activities	(38,727)	(47,475)
Financing activities:
Proceeds from issuance of long-term debt, net of debt issuance costs	0	924,299
Repayment and refinancing of long-term debt	0	(927,046)
Principal payments on long-term debt	(1,901)	(1,613)
Proceeds from (Repayments of) Lines of Credit	0	120,000
Decrease in short-term debt, net	(2,356)	(1,241)
Debt issuance costs and other fees	(1,921)	(74,376)
Taxes withheld and paid on employees' share-based payment awards	(612)	(214)
Other	0	(439)
Net cash (used in) provided by financing activities	(6,790)	39,370
Effects of exchange rate changes on cash, cash equivalents and restricted cash	(2,569)	(8,307)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	(46,439)	21,204
Cash, cash equivalents and restricted cash at beginning of period	163,061	192,807
Cash, cash equivalents and restricted cash at end of period	$ 116,622	$ 214,011